Impact of vomiting on P2Y12 platelet inhibition in patients with ST-elevation myocardial infarction: A prespecified subanalysis of the ON-TIME 3 trial

Research output: Contribution to journalLetterAcademicpeer-review

Abstract

Vomiting is associated with lower levels of ticagrelor concentration and higher platelet reactivity in the early hours of ST-elevation myocardial infarction. These results support reloading with a ticagrelor loading dose and/or treatment with intravenous platelet inhibitors when patients vomit.

Original languageEnglish
Pages (from-to)39-42
Number of pages4
JournalAmerican Heart Journal
Volume243
DOIs
Publication statusPublished - Jan 2022
Externally publishedYes

Fingerprint

Dive into the research topics of 'Impact of vomiting on P2Y12 platelet inhibition in patients with ST-elevation myocardial infarction: A prespecified subanalysis of the ON-TIME 3 trial'. Together they form a unique fingerprint.

Cite this